• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CD34和D2-40在皮肤纤维瘤和隆突性皮肤纤维肉瘤分化中的作用

The Role of CD34 and D2-40 in the Differentiation of Dermatofibroma and Dermatofibrosarcoma Protuberans.

作者信息

Sadullahoğlu Canan, Dere Yelda, Atasever Türkan Rezanko, Öztop Mine Tunakan, Karaaslan Önder

机构信息

Department of Pathology, Antalya Training and Research Hospital, Antalya, Turkey.

出版信息

Turk Patoloji Derg. 2017;1(1):223-227. doi: 10.5146/tjpath.2017.01402.

DOI:10.5146/tjpath.2017.01402
PMID:28832078
Abstract

OBJECTIVE

Dermatofibroma (DF) is a benign fibrohistiocytic tumor whereas dermatofibrosarcoma protuberans (DFSP) has intermediate malignant potential. CD34 is the most commonly used antibody in differentiating these tumors. Various studies have stated the rates of D2-40 expression as 0-50% in DFSPs and 86-100% in DFs. Our aim in this study was to determine the expression of CD34 and D2-40 in DFs and DFSPs and the possible use of D2-40 in the differential diagnosis of these lesions.

MATERIAL AND METHOD

This is a retrospective study including 30 DF and 15 DFSP cases which were reevaluated for epidermal changes, the presence of a transmission zone (Grenz zone), infiltration of soft tissues, infiltration pattern and histologic subtypes in addition to cellular pleomorphism, nuclear atypia, and necrosis. A manual immunohistochemistry procedure was performed with D2-40 and CD 34 antibodies using a representative paraffin block.

RESULTS

The average age was 37.36 and 42.86 years in the DF and DFSP cases. The average diameter was 0.9 and 5.03 cm, respectively, for the DFs and DFSPs. There was a significant correlation between the two entities for sex, localization and diameter of the lesion. A significant difference was found between the positivity of CD34 and D2-40 in DFs and DFSPs.

CONCLUSION

Additional immunohistochemical markers may be needed in DFs with CD34 positivity. Our results showed the additional helpful role of this marker in problematic cases.

摘要

目的

皮肤纤维瘤(DF)是一种良性纤维组织细胞瘤,而隆突性皮肤纤维肉瘤(DFSP)具有中等恶性潜能。CD34是鉴别这些肿瘤最常用的抗体。各种研究表明,DFSP中D2-40的表达率为0%-50%,DF中为86%-100%。本研究的目的是确定CD34和D2-40在DF和DFSP中的表达情况,以及D2-40在这些病变鉴别诊断中的可能用途。

材料与方法

这是一项回顾性研究,纳入30例DF和15例DFSP病例,除了细胞多形性、核异型性和坏死外,还对表皮变化、移行带(无细胞带)的存在、软组织浸润、浸润模式和组织学亚型进行了重新评估。使用代表性石蜡块,采用手动免疫组织化学方法检测D2-40和CD 34抗体。

结果

DF和DFSP病例的平均年龄分别为37.36岁和42.86岁。DF和DFSP的平均直径分别为0.9 cm和5.03 cm。在病变的性别、部位和直径方面,这两种实体之间存在显著相关性。DF和DFSP中CD34和D2-40的阳性率存在显著差异。

结论

CD34阳性的DF可能需要额外的免疫组织化学标志物。我们的结果显示了该标志物在疑难病例中的额外辅助作用。

相似文献

1
The Role of CD34 and D2-40 in the Differentiation of Dermatofibroma and Dermatofibrosarcoma Protuberans.CD34和D2-40在皮肤纤维瘤和隆突性皮肤纤维肉瘤分化中的作用
Turk Patoloji Derg. 2017;1(1):223-227. doi: 10.5146/tjpath.2017.01402.
2
CD34 and factor-XIIIa immunoreactivity in dermatofibrosarcoma protuberans and dermatofibroma.隆突性皮肤纤维肉瘤和皮肤纤维瘤中的CD34及凝血因子XIIIa免疫反应性
Am J Dermatopathol. 1997 Apr;19(2):147-53. doi: 10.1097/00000372-199704000-00008.
3
Differential expression of HMGA1 and HMGA2 in dermatofibroma and dermatofibrosarcoma protuberans: potential diagnostic applications, and comparison with histologic findings, CD34, and factor XIIIa immunoreactivity.HMGA1和HMGA2在皮肤纤维瘤和隆突性皮肤纤维肉瘤中的差异表达:潜在的诊断应用,以及与组织学结果、CD34和凝血因子XIIIa免疫反应性的比较
Am J Dermatopathol. 2004 Aug;26(4):267-72. doi: 10.1097/00000372-200408000-00001.
4
Tenascin differentiates dermatofibroma from dermatofibrosarcoma protuberans: comparison with CD34 and factor XIIIa.腱生蛋白可将皮肤纤维瘤与隆突性皮肤纤维肉瘤区分开来:与CD34和因子ⅩⅢa的比较
Hum Pathol. 2001 Jan;32(1):50-6. doi: 10.1053/hupa.2001.21137.
5
D2-40, a novel immunohistochemical marker in differentiating dermatofibroma from dermatofibrosarcoma protuberans.D2-40 在鉴别纤维瘤型和隆突性皮肤纤维肉瘤中的作用。
Mod Pathol. 2010 Mar;23(3):434-8. doi: 10.1038/modpathol.2009.176. Epub 2010 Jan 8.
6
Stromelysin-3 expression in the differential diagnosis of dermatofibroma and dermatofibrosarcoma protuberans: comparison with factor XIIIa and CD34.基质溶解素-3在皮肤纤维瘤和隆突性皮肤纤维肉瘤鉴别诊断中的表达:与ⅩⅢa因子和CD34的比较
Br J Dermatol. 2007 Aug;157(2):319-24. doi: 10.1111/j.1365-2133.2007.08033.x. Epub 2007 Jun 26.
7
Expression of CD163 in dermatofibroma, cellular fibrous histiocytoma, and dermatofibrosarcoma protuberans: comparison with CD68, CD34, and Factor XIIIa.CD163在皮肤纤维瘤、细胞性纤维组织细胞瘤和隆突性皮肤纤维肉瘤中的表达:与CD68、CD34和因子ⅩⅢa的比较
J Cutan Pathol. 2006 May;33(5):353-60. doi: 10.1111/j.0303-6987.2006.00439.x.
8
Immunohistochemical analysis of platelet-derived growth factor and its receptors in fibrohistiocytic tumors.纤维组织细胞瘤中血小板衍生生长因子及其受体的免疫组织化学分析
J Cutan Pathol. 1997 Aug;24(7):393-7. doi: 10.1111/j.1600-0560.1997.tb00812.x.
9
Apolipoprotein D in CD34-positive and CD34-negative cutaneous neoplasms: a useful marker in differentiating superficial acral fibromyxoma from dermatofibrosarcoma protuberans.载脂蛋白D在CD34阳性和CD34阴性皮肤肿瘤中的表达:鉴别浅表性肢端纤维黏液瘤与隆突性皮肤纤维肉瘤的有用标志物。
Mod Pathol. 2008 Jan;21(1):31-8. doi: 10.1038/modpathol.3800971. Epub 2007 Sep 21.
10
Dermatofibroma and dermatofibrosarcoma protuberans: an immunohistochemical study reveals distinctive antigenic profiles.皮肤纤维瘤和隆突性皮肤纤维肉瘤:一项免疫组织化学研究揭示了独特的抗原谱。
J Dermatol Sci. 1996 Jan;11(1):1-9. doi: 10.1016/0923-1811(95)00409-2.

引用本文的文献

1
Dermatofibrosarcoma Protuberans Occurring in an Adult Presenting with Chronic Lymphedema: A Case Study and Literature Review.隆突性皮肤纤维肉瘤成人病例伴慢性淋巴水肿:病例研究与文献回顾。
Am J Case Rep. 2023 Dec 15;24:e941142. doi: 10.12659/AJCR.941142.
2
Dermatofibromas with Aberrant Expression of CD34 Protein: A Systematic Review and a Reappraisal of Clinicopathological Features and Histogenesis.伴有CD34蛋白异常表达的皮肤纤维瘤:一项系统评价及对临床病理特征和组织发生的重新评估
Diagnostics (Basel). 2023 Jan 4;13(2):185. doi: 10.3390/diagnostics13020185.
3
Atrophic Dermatofibroma: A Unique Dermatofibroma Variant.
萎缩性皮肤纤维瘤:一种独特的皮肤纤维瘤变体。
Cureus. 2021 Apr 19;13(4):e14570. doi: 10.7759/cureus.14570.
4
Dermatofibrosarcoma protuberans of the breast: A case study.乳腺隆突性皮肤纤维肉瘤:病例报告
Mol Clin Oncol. 2021 Mar;14(3):50. doi: 10.3892/mco.2021.2212. Epub 2021 Jan 20.
5
Wilms' Tumor 1 (WT1): A Novel Immunomarker of Dermatofibrosarcoma Protuberans-An Immunohistochemical Study on a Series of 114 Cases of Bland-Looking Mesenchymal Spindle Cell Lesions of the Dermis/Subcutaneous Tissues.肾母细胞瘤1(WT1):隆突性皮肤纤维肉瘤的一种新型免疫标志物——对114例外观平淡的真皮/皮下组织间质性梭形细胞病变的免疫组织化学研究
Cancers (Basel). 2021 Jan 12;13(2):252. doi: 10.3390/cancers13020252.
6
Dermatofibrosarcoma of The Breast - Case Report and Review of Literature.乳腺隆突性皮肤纤维肉瘤——病例报告及文献综述
Eur J Breast Health. 2018 Oct 1;14(4):234-237. doi: 10.5152/ejbh.2018.3994. eCollection 2018 Oct.